Nuclear factor-κB: its role in health and disease

Nuclear factor-κB (NF-κB) is a major transcription factor that plays an essential role in several aspects of human health including the development of innate and adaptive immunity. The dysregulation of NF-κB is associated with many disease states such as AIDS, atherosclerosis, asthma, arthritis, cancer, diabetes, inflammatory bowel disease, muscular dystrophy, stroke, and viral infections. Recent evidence also suggests that the dysfunction of NF-κB is a major mediator of some human genetic disorders. Appropriate regulation and control of NF-κB activity, which can be achieved by gene modification or pharmacological strategies, would provide a potential approach for the management of NF-κB related human diseases. This review summarizes the current knowledge of the physiological and pathophysiological functions of NF-κB and its possible role as a target of therapeutic intervention

[1]  Sujay K. Singh,et al.  Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. , 2003, The Journal of biological chemistry.

[2]  T. Ogihara,et al.  In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.

[3]  G. Courtois,et al.  Mature T cells depend on signaling through the IKK complex. , 2003, Immunity.

[4]  C. Kaltschmidt,et al.  NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.

[5]  P. Barnes,et al.  Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.

[6]  F. Autschbach,et al.  Cell specific effects of glucocorticoid treatment on the NF-κBp65/IκBα system in patients with Crohn’s disease , 1999 .

[7]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[8]  E. Ho,et al.  Antioxidants, NFκB Activation, and Diabetogenesis , 1999 .

[9]  B. Aggarwal,et al.  Nuclear Transcription Factor-kappaB in Hodgkin's Disease , 2003, Leukemia & lymphoma.

[10]  M. Wainberg,et al.  Inducible Expression of IκBα Repressor Mutants Interferes with NF-κB Activity and HIV-1 Replication in Jurkat T Cells* , 1998, The Journal of Biological Chemistry.

[11]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[12]  T. Lawrence,et al.  Possible new role for NF-κB in the resolution of inflammation , 2001, Nature Medicine.

[13]  G. Hansson,et al.  Nuclear factor kappa-B and the heart. , 2001, Journal of the American College of Cardiology.

[14]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[15]  Ashok Kumar,et al.  Mechanical stress activates the nuclear factor‐kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  K. Wilkinson Signal transduction: Aspirin, ubiquitin and cancer , 2003, Nature.

[17]  J. Tidball,et al.  Do immune cells promote the pathology of dystrophin-deficient myopathies? , 2001, Neuromuscular Disorders.

[18]  R. Gaynor,et al.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.

[19]  A. Baldwin,et al.  NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Nabel,et al.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1990, Nature.

[21]  D. Wallach,et al.  MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.

[22]  Zhaodan Cao,et al.  NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 , 1998 .

[23]  Kozo Nakamura,et al.  A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders , 2002, Journal of Bone and Mineral Metabolism.

[24]  M. Mattson,et al.  NF-kappaB in neuronal plasticity and neurodegenerative disorders. , 2001, The Journal of clinical investigation.

[25]  David Baltimore,et al.  Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.

[26]  F. Weih,et al.  Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.

[27]  K. Miyazawa,et al.  Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappaB and CBF1. , 1998, The American journal of pathology.

[28]  P. Baeuerle,et al.  NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation. , 1997, Biochemical Society transactions.

[29]  M. Wainberg,et al.  Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells. , 1998, The Journal of biological chemistry.

[30]  P. Herrlich,et al.  Sequential DNA damage‐independent and ‐dependent activation of NF‐κB by UV , 1998 .

[31]  A. D'amico,et al.  RelB Is Essential for the Development of Myeloid-Related CD8α− Dendritic Cells but Not of Lymphoid-Related CD8α+ Dendritic Cells , 1998 .

[32]  M. Cybulsky,et al.  NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? , 2001, The Journal of clinical investigation.

[33]  R. Chaganti,et al.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.

[34]  S. Akira,et al.  Brief Definitive Report Essential Role of Nuclear Factor (nf)-␬ B–inducing Kinase and Inhibitor of ␬ B (i ␬ B) Kinase ␣ in Nf-␬ B Activation through Lymphotoxin ␤ Receptor, but Not through Tumor Necrosis Factor Receptor I , 2022 .

[35]  D. Nelson,et al.  NF-kappaB signaling and human disease. , 2001, Current opinion in genetics & development.

[36]  D. Donnai,et al.  Incontinentia pigmenti (Bloch-Sulzberger syndrome). , 1993, Journal of medical genetics.

[37]  A. Hida,et al.  Importance of NF-κB in rheumatoid synovial tissues: in situ NF-κB expression and in vitro study using cultured synovial cells , 2001 .

[38]  I. Verma,et al.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. , 1999, Science.

[39]  Michael Karin,et al.  NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.

[40]  P. Elliott,et al.  Proteasome Inhibition: a New Strategy in Cancer Treatment , 2000, Investigational New Drugs.

[41]  Jennifer Y. Zhang,et al.  NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. , 2003, Nature.

[42]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kappaB pathway. , 2001, The Journal of clinical investigation.

[43]  A. Hoffmann,et al.  CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response. , 2003, Molecular cell.

[44]  Y. Ahn,et al.  A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response , 2003, Circulation.

[45]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[46]  David Baltimore,et al.  Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.

[47]  S. Johnston,et al.  Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[48]  G. Bonizzi,et al.  Mechanisms of Persistent NF-κB Activity in the Bronchi of an Animal Model of Asthma1 , 2000, The Journal of Immunology.

[49]  C. Bever,et al.  Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor. , 2001, International journal of molecular medicine.

[50]  G. Vita,et al.  Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. , 2003, Neurology.

[51]  J. Beckmann,et al.  Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IκBα/NF-κB survival pathway in skeletal muscle , 2001, Journal of Molecular Medicine.

[52]  Burkhard Haefner,et al.  NF-κB: arresting a major culprit in cancer , 2002 .

[53]  R. Hay,et al.  Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.

[54]  C. Hunter,et al.  NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions , 2002, Clinical Microbiology Reviews.

[55]  I. Adcock,et al.  Inducible nitric oxide synthase after sensitization and allergen challenge of Brown Norway rat lung , 1997, British journal of pharmacology.

[56]  P. Khavari,et al.  Divergent gene regulation and growth effects by NF-κB in epithelial and mesenchymal cells of human skin , 2003, Oncogene.

[57]  E. Zandi,et al.  A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. , 1997, Nature.

[58]  T. Maniatis,et al.  NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .

[59]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[60]  A. Lin,et al.  Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Hector R. Wong,et al.  Nuclear factor-κB as a therapeutic target in critical care medicine , 2003 .

[62]  T. Rando,et al.  NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. , 2001, Free radical biology & medicine.

[63]  M. Karin,et al.  The IKK/NF-kappaB pathway. , 2002, Critical care medicine.

[64]  M. Cybulsky,et al.  Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.

[65]  D. Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. , 1995, Nature.

[66]  I. Adcock,et al.  Effects of inhaled β agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma , 1999, Thorax.

[67]  C. Kaltschmidt,et al.  NF-kappa B: a crucial transcription factor for glial and neuronal cell function. , 1997, Trends in neurosciences.

[68]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[69]  W. Sha,et al.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. , 1999, Immunity.

[70]  M. Mcdaniel,et al.  Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. , 1995, Endocrinology.

[71]  T. Serikawa,et al.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. , 1999, Nature genetics.

[72]  B. Aggarwal,et al.  Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation. , 1996, The Journal of biological chemistry.

[73]  D. Baltimore,et al.  B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. , 1996, Journal of immunology.

[74]  M. Karin,et al.  Is NF-kappaB the sensor of oxidative stress? , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  T. Maniatis,et al.  Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. , 1996, Cell.

[76]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.

[77]  I. Rodger,et al.  Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. , 1998, Circulation.

[78]  C. Nguyên,et al.  A Small Molecule Inhibitor of Redox-Regulated NF-κB and Activator Protein-1 Transcription Blocks Allergic Airway Inflammation in a Mouse Asthma Model1 , 2002, The Journal of Immunology.

[79]  J. D. Porter,et al.  A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. , 2002, Human molecular genetics.

[80]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kB pathway , 2001 .

[81]  M. Mattson,et al.  Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[83]  B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[84]  B. Aggarwal,et al.  Site-specific Tyrosine Phosphorylation of IκBα Negatively Regulates Its Inducible Phosphorylation and Degradation* , 1996, The Journal of Biological Chemistry.

[85]  Yasushi Matsumura,et al.  Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002, Circulation.

[86]  J. Engelhardt,et al.  Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. , 2003, The Journal of biological chemistry.

[87]  C. Irvin,et al.  Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. , 2002, The American journal of pathology.

[88]  P. Herrlich,et al.  Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV. , 1998, The EMBO journal.

[89]  G. A. Limb,et al.  Activation of nuclear factor kappa B in Crohn's disease , 1998, Inflammation Research.

[90]  E. Schmidt,et al.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. , 2001, Cell.

[91]  S. Klauck,et al.  Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. , 2000, Nature.

[92]  T. Bauer Particles and periimplant bone resorption. , 2002, Clinical orthopaedics and related research.

[93]  Céline Gélinas,et al.  Rel/NF‐κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors , 1999, The EMBO journal.

[94]  L. Cro,et al.  Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. , 1993, Oncogene.

[95]  A. Leonardi,et al.  Requirement for NF-kappaB in osteoclast and B-cell development. , 1997, Genes & development.

[96]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.

[97]  Lu Zhou,et al.  NFκB and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells , 2001 .

[98]  Richard T. Lee,et al.  Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. , 2004, The Journal of clinical investigation.

[99]  J. Christman,et al.  The role of nuclear factor-kappa B in pulmonary diseases. , 2000, Chest.

[100]  M. Karin,et al.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.

[101]  C. Snapper,et al.  Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses , 1998, The Journal of experimental medicine.

[102]  J. Cusack,et al.  Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB , 1999, Nature Medicine.

[103]  T. Mak,et al.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.

[104]  Ulrich Siebenlist,et al.  Requirement for NF-κB in osteoclast and B-cell development , 1997 .

[105]  J. Molkentin,et al.  Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? , 2003, Circulation.

[106]  A. Lin,et al.  Activation of nuclear factor- B is necessary for myotrophin-induced cardiac hypertrophy , 2002 .

[107]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[108]  S. Gerondakis,et al.  Rel/NF‐κB transcription factors: key mediators of B‐cell activation , 2000 .

[109]  J. Beckmann,et al.  Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice , 2000, The Journal of cell biology.

[110]  J. Hoidal,et al.  NADPH oxidase promotes NF-kappaB activation and proliferation in human airway smooth muscle. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[111]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. , 1998, Nature.

[112]  A. Smahi,et al.  The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. , 2002, Human molecular genetics.

[113]  M. Neurath,et al.  Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice , 1996, Nature Medicine.

[114]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[115]  R. Chaganti,et al.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. , 1991, Cell.

[116]  J. Beckmann,et al.  Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. , 1999, Nature medicine.

[117]  Michael Karin,et al.  The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation* , 1999, The Journal of Biological Chemistry.

[118]  Nanxin Li,et al.  Oxidative stress and gene expression: The AP‐1 and NF‐κB connections , 2001 .

[119]  M. Karin,et al.  IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. , 2001, Immunity.

[120]  D. Goeddel,et al.  NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[121]  J. Prehn,et al.  Activation of Nuclear Factor κb and bcl-x Survival Gene Expression by Nerve Growth Factor Requires Tyrosine Phosphorylation of IκBα , 2001, The Journal of cell biology.

[122]  F. Autschbach,et al.  Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. , 1999, Gut.

[123]  S. Akira,et al.  Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.

[124]  E. Zandi,et al.  The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. , 1997, Cell.

[125]  G. Moretto,et al.  Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. , 1999, The American journal of pathology.

[126]  J. Christman,et al.  Impact of Basic Research on Tomorrow's MedicineThe Role of Nuclear Factor-κ B in Pulmonary Diseases , 2000 .

[127]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[128]  Y. Abu-Amer,et al.  NF-κB and bone: The breaking point , 1997, Nature Medicine.

[129]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[130]  D. Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986. 46: 705-716. , 2006, Journal of immunology.

[131]  P. Ricciardi-Castagnoli,et al.  Brief Definitive Report Dendritic Cell Survival and Maturation Are Regulated by Different Signaling Pathways , 2022 .

[132]  J. Newcombe,et al.  Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions. , 1998, Journal of neuropathology and experimental neurology.

[133]  B. Volk,et al.  Inhibition of NF-kB potentiates amyloid b-mediated neuronal apoptosis (IkB-aytumor necrosis factoryoxidative stressyneuroprotectionypreconditioning) , 1999 .

[134]  E. Schmidt,et al.  IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.

[135]  G. Courtois,et al.  Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.

[136]  Sergei S Makarov,et al.  NF-kappaB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction , 2001, Arthritis research.

[137]  D. Carrasco,et al.  The v‐rel oncogene promotes malignant T‐cell leukemia/lymphoma in transgenic mice. , 1996, The EMBO journal.

[138]  M. Feldmann,et al.  Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[139]  I. Adcock,et al.  Transcription factors and asthma. , 1998, The European respiratory journal.

[140]  J. Schaper,et al.  Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. , 1997, European heart journal.

[141]  P. Khavari,et al.  Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[142]  S. Gerondakis,et al.  The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation. , 1998, Current opinion in immunology.

[143]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[144]  P. Keng,et al.  Expression of Either NF‐κB p50 or p52 in Osteoclast Precursors Is Required for IL‐1‐Induced Bone Resorption , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[145]  C. Mueller-Dieckmann,et al.  Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. , 1996, Cell.

[146]  P. Khavari,et al.  Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .

[147]  Burkhard Haefner,et al.  NF-kappa B: arresting a major culprit in cancer. , 2002, Drug discovery today.

[148]  I. Adcock,et al.  Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma. , 2000, American journal of respiratory and critical care medicine.

[149]  N. Paran,et al.  Activation of NF-κB by hepatitis B virus X protein through an IκB kinase-independent mechanism , 2001 .

[150]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[151]  A. Hoffmann,et al.  CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response , 2003 .

[152]  I. Adcock,et al.  Ozone induction of cytokine‐induced neutrophil chemoattractant (CINC) and nuclear factor‐κb in rat lung: inhibition by corticosteroids , 1996, FEBS letters.

[153]  B. Aggarwal,et al.  Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. , 1998, The Journal of biological chemistry.

[154]  Nanxin Li,et al.  Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[155]  Michael Karin,et al.  Is NF‐κB the sensor of oxidative stress? , 1999 .

[156]  T. Maniatis,et al.  Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.

[157]  G. Freeman,et al.  Induction of nuclear factor κB and activation protein 1 in postischemic myocardium , 1997, FEBS letters.

[158]  M. Stacey,et al.  The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. , 1997, Biochemical and biophysical research communications.

[159]  D. Baltimore,et al.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. , 1986, Cell.

[160]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[161]  C. Angermann,et al.  Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. , 2003, Cardiovascular research.

[162]  M. Okabe,et al.  Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-alpha-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis. , 1999, Journal of immunology.

[163]  B. Hilliard,et al.  Transcriptional Regulation of Type I Diabetes by NF-κB 1 , 2003, The Journal of Immunology.

[164]  Wei-Ping Qian,et al.  IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor κB ligand and tumor necrosis factor α from T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[165]  D. Holmes,et al.  Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia. , 2000, Atherosclerosis.

[166]  D. Eizirik,et al.  Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. , 2001, Diabetes.

[167]  J. Beckmann,et al.  Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle. , 2001, Journal of molecular medicine.

[168]  M. Karin,et al.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. , 2000, Seminars in immunology.

[169]  T. Deerinck,et al.  The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.

[170]  M. Karin,et al.  The IKK/NF-kappa B pathway. , 2002 .

[171]  Sujay K. Singh,et al.  Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. , 2003, Blood.

[172]  Shokei Kim,et al.  Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. , 1998, Cardiovascular research.

[173]  A. Strasser,et al.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.

[174]  Xianglin Shi,et al.  New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation , 2001 .

[175]  Lung-Chi Chen,et al.  Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. , 1997, The American journal of physiology.

[176]  E. Oltz,et al.  An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets , 1999 .

[177]  R. Knuechel,et al.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.

[178]  J. Tidball,et al.  Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. , 2001, Clinical immunology.

[179]  D. White,et al.  Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.

[180]  E. Ho,et al.  Antioxidants, NFkappaB activation, and diabetogenesis. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[181]  I. Adcock,et al.  Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. , 1998, American journal of respiratory and critical care medicine.

[182]  A. Sica,et al.  Interaction of NF-κB and NFAT with the Interferon-γ Promoter* , 1997, The Journal of Biological Chemistry.

[183]  N. Tarantino,et al.  In Vivo Inhibition of NF-κB in T-Lineage Cells Leads to a Dramatic Decrease in Cell Proliferation and Cytokine Production and to Increased Cell Apoptosis in Response to Mitogenic Stimuli, But Not to Abnormal Thymopoiesis , 1999, The Journal of Immunology.

[184]  細田 昌良 Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils , 2003 .

[185]  Y. Ben-Neriah Regulatory functions of ubiquitination in the immune system , 2002, Nature Immunology.

[186]  P. Baeuerle,et al.  Role of nuclear factor‐kappa B in atherogenesis , 1997, Experimental physiology.

[187]  J. Tidball,et al.  Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. , 1997, The Journal of clinical investigation.

[188]  G. Courtois,et al.  Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. , 1998, Cell.

[189]  P. Baeuerle,et al.  Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. , 1996, Arthritis and rheumatism.

[190]  B. Aggarwal,et al.  Nuclear factor-kappa B and cancer: its role in prevention and therapy. , 2002, Biochemical pharmacology.

[191]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[192]  D. Corry,et al.  Mechanical stretch activates nuclear factor‐kappaB, activator protein‐1, and mitogen‐activated protein kinases in lung parenchyma: implications in asthma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[193]  Claus Scheidereit,et al.  NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.

[194]  B. Aggarwal,et al.  Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines , 2001, Oncogene.

[195]  Swaroop Aradhya,et al.  NF-κB signaling and human disease , 2001 .

[196]  Stuart A. Lipton,et al.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.

[197]  Mark P. Mattson,et al.  NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .

[198]  A. Hida,et al.  Importance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cells. , 2001, Annals of the rheumatic diseases.

[199]  R. Surabhi,et al.  RNA Interference Directed against Viral and Cellular Targets Inhibits Human Immunodeficiency Virus Type 1 Replication , 2002, Journal of Virology.

[200]  E. Zandi,et al.  IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. , 1998, Nature.

[201]  E. Hirsch,et al.  Nuclear translocation of NF‐κB in cholinergic neurons of patients with Alzheimer's disease , 1997, Neuroreport.

[202]  M. Boothby,et al.  Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB , 1997, The Journal of experimental medicine.

[203]  S. Klauck,et al.  Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti , 2000, Nature.

[204]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[205]  J. Inoue,et al.  Induction of interleukin‐12 p40 transcript by CD40 ligation via activation of nuclear factor‐xB , 1997, European journal of immunology.

[206]  S. Johnston,et al.  Respiratory Epithelial Cell Expression of Vascular Cell Adhesion Molecule-1 and Its Up-regulation by Rhinovirus Infection via NF-κB and GATA Transcription Factors* , 1999, The Journal of Biological Chemistry.

[207]  F. Chen,et al.  New insights into the role of nuclear factor-kappaB in cell growth regulation. , 2001, The American journal of pathology.

[208]  R. Coffey,et al.  Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN , 2001, Oncogene.

[209]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[210]  V. Godfrey,et al.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. , 2000, Molecular cell.

[211]  Sujay K. Singh,et al.  Hydrogen Peroxide Activates NF-κB through Tyrosine Phosphorylation of IκBα and Serine Phosphorylation of p65 , 2003, Journal of Biological Chemistry.

[212]  L. Ährlund‐Richter,et al.  Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. , 1999, Cancer research.

[213]  J. Egido,et al.  Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet. , 2003, Cardiovascular research.

[214]  T. Deerinck,et al.  Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. , 1999, Science.

[215]  E. Oltz,et al.  An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets. , 1999, Molecular immunology.

[216]  A. D'amico,et al.  RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. , 1998, Immunity.

[217]  G. Bonizzi,et al.  Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. , 2000, American journal of respiratory and critical care medicine.

[218]  D. Lo,et al.  Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.

[219]  Michael Karin,et al.  The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling , 2000 .

[220]  Wei-Ping Qian,et al.  IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[221]  K. Jeang,et al.  Potent and Stable Attenuation of Live-HIV-1 by Gain of a Proteolysis-resistant Inhibitor of NF-κB (IκB-αS32/36A) and the Implications for Vaccine Development* , 1999, The Journal of Biological Chemistry.

[222]  Sujay K. Singh,et al.  Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis , 2003 .

[223]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[224]  Y. Obata,et al.  NF-κB RelA-deficient Lymphocytes: Normal Development of  T Cells and B Cells, Impaired Production of IgA and IgG1 and Reduced Proliferative Responses , 1997, The Journal of experimental medicine.

[225]  M. Boothby,et al.  NF-κB/Rel Participation in the Lymphokine-Dependent Proliferation of T Lymphoid Cells1 , 2001, The Journal of Immunology.

[226]  S. Manna,et al.  Pervanadate-induced Nuclear Factor-κB Activation Requires Tyrosine Phosphorylation and Degradation of IκBα , 2000, The Journal of Biological Chemistry.

[227]  E. Ho,et al.  Supplementation of N‐acetylcysteine inhibits NFκB activation and protects against alloxan‐induced diabetes in CD‐1 mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[228]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[229]  C. Snapper,et al.  Multiple Hemopoietic Defects and Lymphoid Hyperplasia in Mice Lacking the Transcriptional Activation Domain of the c-Rel Protein , 1998, The Journal of experimental medicine.

[230]  M. Cybulsky,et al.  NF-κB: pivotal mediator or innocent bystander in atherogenesis? , 2001 .

[231]  M. Karin,et al.  IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis , 2001 .

[232]  C. Tato,et al.  Identification of a Role for NF-κB2 in the Regulation of Apoptosis and in Maintenance of T Cell-Mediated Immunity to Toxoplasma gondii1 , 2000, The Journal of Immunology.

[233]  T. Lawrence,et al.  Possible new role for NF-kappaB in the resolution of inflammation. , 2001, Nature medicine.

[234]  T. Maniatis,et al.  MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[235]  G. Kollias,et al.  Tumor necrosis factor‐α/nuclear transcription factor‐κB signaling in periprosthetic osteolysis , 2000 .

[236]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[237]  G. Vita,et al.  Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy , 2003, Neurology.

[238]  A. Sica,et al.  Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. , 1997, The Journal of biological chemistry.

[239]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[240]  M. Stacey,et al.  The Allergen Der p1 Induces NF-kB Activation through Interference with IkBα Function in Asthmatic Bronchial Epithelial Cells , 1997 .

[241]  Y. Abu-Amer,et al.  NF-kappaB and bone: the breaking point. , 1997, Nature medicine.

[242]  T. Deerinck,et al.  Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .

[243]  B. Mitchell The proteasome--an emerging therapeutic target in cancer. , 2003, The New England journal of medicine.

[244]  B. Aggarwal,et al.  Antiproliferative Effects of IFN-α Correlate with the Downregulation of Nuclear Factor-κB in Human Burkitt Lymphoma Daudi Cells , 2001 .

[245]  S. Manna,et al.  Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha. , 2000, The Journal of biological chemistry.

[246]  E. Zandi,et al.  IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.

[247]  J. D. Porter,et al.  Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. , 2003, Human molecular genetics.